BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12834788)

  • 1. Pharmacokinetics and feeding responses to muramyl dipeptide in rats.
    Fosset S; Fromentin G; Rampin O; Lang V; Mathieu F; Tomé D
    Physiol Behav; 2003 Jul; 79(2):173-82. PubMed ID: 12834788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of bacterial lipopolysaccharide and muramyl dipeptide on food intake.
    Langhans W; Harlacher R; Balkowski G; Scharrer E
    Physiol Behav; 1990 May; 47(5):805-13. PubMed ID: 2388934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential feeding responses to bacterial lipopolysaccharide and muramyl dipeptide.
    Langhans W; Balkowski G; Savoldelli D
    Am J Physiol; 1991 Sep; 261(3 Pt 2):R659-64. PubMed ID: 1887952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of muramyl dipeptide by mammalian serum.
    Harrison J; Fox A
    Infect Immun; 1985 Oct; 50(1):320-1. PubMed ID: 3876287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetyl muramyl dipeptide stimulation of bone resorption in tissue culture.
    Dewhirst FE
    Infect Immun; 1982 Jan; 35(1):133-7. PubMed ID: 7054120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in the effects of muramyl dipeptide and lipopolysaccharide on locomotor activity and the development of behavioral tolerance in rats.
    Engeland CG; Kavaliers M; Ossenkopp KP
    Pharmacol Biochem Behav; 2003 Jan; 74(2):433-47. PubMed ID: 12479965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vagal and splanchnic afferents are not necessary for the anorexia produced by peripheral IL-1beta, LPS, and MDP.
    Porter MH; Hrupka BJ; Langhans W; Schwartz GJ
    Am J Physiol; 1998 Aug; 275(2):R384-9. PubMed ID: 9688672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of quiet sleep in rabbit neonates by muramyl dipeptide.
    Davenne D; Krueger JM
    Am J Physiol; 1987 Oct; 253(4 Pt 2):R646-54. PubMed ID: 3661760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and metabolism of muramyl dipeptide and nor-muramyl dipeptide [3H-labelled] in the mouse.
    Ambler L; Hudson AM
    Int J Immunopharmacol; 1984; 6(2):133-9. PubMed ID: 6735535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid elimination of a synthetic adjuvant peptide from the circulation after systemic administration and absence of detectable natural muramyl peptides in normal serum at current analytical limits.
    Fox A; Fox K
    Infect Immun; 1991 Mar; 59(3):1202-5. PubMed ID: 1997424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposite effects of the synthetic adjuvant N-acetyl-muramyl-L-alanyl-D-isoglutamine on the immune response in mice depending on experimental conditions.
    Souvannavong V; Adam A
    Eur J Immunol; 1980 Aug; 10(8):654-6. PubMed ID: 6995138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muramyl dipeptide-induced sleep and fever: effects of ambient temperature and time of injections.
    Shoham S; Krueger JM
    Am J Physiol; 1988 Jul; 255(1 Pt 2):R157-65. PubMed ID: 3394839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central pyrogenic activity of muramyl dipeptide.
    Riveau G; Masek K; Parant M; Chedid L
    J Exp Med; 1980 Oct; 152(4):869-77. PubMed ID: 7420023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential sleep modulation by sequentially administered muramyl dipeptide and uridine.
    Kimura-Takeuchi M; Inoué S
    Brain Res Bull; 1993; 31(1-2):33-7. PubMed ID: 8453493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Heymer B; Finger H; Wirsing CH
    Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of N-acetyl-muramyl-L-alanyl-D-isoglutamine on interferon production in mice by Newcastle disease virus.
    Sakuma T; Azuma M; Yoshida I
    J Gen Virol; 1984 May; 65 ( Pt 5)():999-1003. PubMed ID: 6202835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroimmune intercommunication, central opioids, and the immune response to bacterial endotoxin.
    Dougherty PM; Dafny N
    J Neurosci Res; 1988; 19(1):140-8. PubMed ID: 3343705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muramyl-dipeptide-induced fever in cats.
    Amini-Sereshki-Kormi L
    Pathobiology; 1996; 64(5):279-83. PubMed ID: 9068012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of endogenous pyrogen-induced fever by a muramyl dipeptide derivative.
    Parant M; Riveau G; Parant F; Chedid L
    Am J Physiol; 1984 Sep; 247(3 Pt 1):C169-74. PubMed ID: 6476105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral acute pyogenic conjunctivitis with iritis induced by unilateral topical application of bacterial peptidoglycan muramyl dipeptide in adult rabbits.
    Langford MP; Foreman BD; Srur L; Ganley JP; Redens TB
    Exp Eye Res; 2013 Nov; 116():324-36. PubMed ID: 24135297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.